VERONA PHARMA PLC - AM

Verona Pharma Reports TQT Study Successfully Demonstrated No Clinically Relevant Effect on Cardiac Conduction

15 ديسمبر 2021 23:00:00 بحسب Nasdaq GlobeNewswire

Verona Pharma Reports Third Quarter 2021 Financial Results and Provides Corporate Update

08 نوفمبر 2021 23:00:00 بحسب Nasdaq GlobeNewswire

Verona Pharma to Report Third Quarter 2021 Financial Results and Provide Corporate Update

25 أكتوبر 2021 23:00:00 بحسب Nasdaq GlobeNewswire

Verona Pharma to Present Phase 2 Data with pMDI Ensifentrine in COPD at CHEST 2021

12 أكتوبر 2021 23:00:00 بحسب Nasdaq GlobeNewswire

Verona Pharma Presents Pharmacokinetic Data with Ensifentrine at the European Respiratory Society International Congress 2021

01 سبتمبر 2021 23:00:00 بحسب Nasdaq GlobeNewswire

Verona Pharma to Present at H.C. Wainwright 23rd Annual Global Investment Conference

30 أغسطس 2021 23:00:00 بحسب Nasdaq GlobeNewswire

Verona Pharma Reports Second Quarter 2021 Financial Results and Provides Corporate Update

04 أغسطس 2021 23:00:00 بحسب Nasdaq GlobeNewswire

Verona Pharma Announces August 2021 Virtual Investor Conference Participation

26 يوليو 2021 23:00:00 بحسب Nasdaq GlobeNewswire

Verona Pharma to Report Second Quarter 2021 Financial Results and Provide Corporate Update

21 يوليو 2021 23:00:00 بحسب Nasdaq GlobeNewswire

Verona Pharma and Nuance Pharma Announce $219 Million Strategic Collaboration to Develop and Commercialize Ensifentrine in Greater China

09 يونيو 2021 23:00:00 بحسب Nasdaq GlobeNewswire

Verona Pharma to Present at Jefferies Virtual Healthcare Conference

24 مايو 2021 23:00:00 بحسب Nasdaq GlobeNewswire

Verona Pharma to Present Expanded Analysis of Phase 2b COPD Data with Ensifentrine at the American Thoracic Society 2021 International Conference

03 مايو 2021 23:00:00 بحسب Nasdaq GlobeNewswire

Verona Pharma Announces Publication of Phase 2b Dose-Ranging COPD Data in the International Journal of Chronic Obstructive Pulmonary Disease

26 أبريل 2021 23:00:00 بحسب Nasdaq GlobeNewswire

Verona Pharma Reports Results of Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19

22 أبريل 2021 23:00:00 بحسب Nasdaq GlobeNewswire

Verona Pharma to Report First Quarter 2021 Financial Results and Provide Corporate Update

20 أبريل 2021 23:00:00 بحسب Nasdaq GlobeNewswire

Lisa Deschamps Joins Verona Pharma as Non-Executive Director

01 مارس 2021 23:00:00 بحسب Nasdaq GlobeNewswire

Verona Pharma to Present at H.C. Wainwright Global Life Sciences Virtual Conference

28 فبراير 2021 23:00:00 بحسب Nasdaq GlobeNewswire

Verona Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

24 فبراير 2021 23:00:00 بحسب Nasdaq GlobeNewswire